Scientific Program
Monday
12:30 — Registration, Poster set up – Session A
13:15 — Opening session
Dr Lucie SANCEY, President of SFNano, Université Grenoble Alpes, Institute for Advanced Biosciences, France
13:30 — Key Note: Pr Sébastien LECOMMANDOUX, Bordeaux INP, France
Biomimetic Dynamic Polymer Self-Assembly:
Engineering Living-Like Matter from Smart Nanomedicine to Artificial Cell Therapy
SESSION 1 — New approaches for nanomedicine: cancer
Chairpersons: Shubaash ANTHIYA & Marie-Pierre ROLS
14:30 — Prof Alexander KROS, University of Leiden, The Netherlands
Understanding the nano-bio interface and molecular self-assembly in LNPs to improve RNA-therapeutics
15:00 — Veronika BORGGRAEFE, Sorbonne University, France
Thermoresponsive molecularly imprinted polymer (MIP) nanogels as synthetic antibody mimics with cell-line specific antiproliferative activity
15:15 — Camille MÉNIER, University of Angers, France
Inhalable chemotherapy nanomedicines: an innovative lung cancer treatment tailored to the microbiota
15:30 — Julie SCHLEDERER, University of Orléans, France
FUS-activated cationic microbubbles for the modulation of microRNA expression in an in vivo orthotopic glioblastoma mouse model
15:45 — Dr Ali MAKKY, University Paris Saclay, France
Light-induced disruptive Porphysomes: A novel strategy to deliver and release hydrophobic photosensitizers
16:00 — Coffee break – Poster set up (Session A)
16:30 — Sponsors Session
16:45 — Oliwia MAJCHRZAK, University of Geneva, Switzerland
EMT-derived extracellular vesicles induce epithelial/mesenchymal remodeling in breast spheroids
17:00 — Eilien HEINRICH, Fraunhofer IMM, Germany
LNP Structure-Function Relationships: From Bleb Formation and Morphology to Biological Performance
17:15 — Thania HAMMOUM, University of Montpellier
Exploiting Tumor Acidity for pH-Responsive siRNA Delivery Using WRAP Based Nanoparticles
17:30 — Dr Davy GUILLARME, University of Geneva, Switzerland
Next-generation chromatographic strategies for the characterization of mRNA in lipid nanoparticle formulations
18:00 — ANR presentation ang General Assembly of SFNano (French Society for Nanomedicine)
19:00 — Welcome Cocktail – Poster session A
Tuesday
8:30 — Registration
SESSION 2 — Imaging, Diagnostic and Theranostic
Chairpersons: Lucie SANCEY & Nicolas TSAPIS
9:00 — Prof Alexandro SOFIAS, Aachen University, Germany
Nanomedicine hitchhiking with immune cells
9:30 — Dr Gabriel Rafael GUERRERO PORRAS, University of Strasbourg, France
Surface engineering of targeted IONPs for improved β-amyloid fibril recognition toward the development of a specific MRI contrast agent
9:45 — Dr Yun LUO, University Paris Cité, France
Prodegradative gold nanocoating for iron bioresorbable stent
10:00 — Dr Marino ATTILIO, Italian Institute of Technology, Italy
Biodegradable piezoelectric chitosan nanotransducers for ultrasound-activated, drug-free cancer therapy
10:15 — Coffee break and Poster Session A
10:45 — Dr Sara MARTINEZ DE LIZRRONDO, University of Caen Normandie, France
Vascular-Targeted Magnetic Particles to image the immune response by MRI and MPI
11:15 — Sophie TREBEL, University of Caen Normandie, France
Relaxation-engineered microtracers for quantitative 3D mapping of neuroinflammation using immuno-Magnetic Particle Imaging
11:30 — Laila YAZIGI, University of Franche-Comté, France
Magnetoplasmonic nanoflowers for image-guided treatment of atherosclerosis
11:45 — Ernestine GAILLARD, University Paris Cité, France
Nanocomposite Hydrogels based on Functionalized Gold Nanotriangles as SERS Platforms for Biomarker Detection
12:00 — Lunch and Poster Session A
SESSION 3 — Chemistry for nanomaterials
Chairpersons: Jeanne LEBLONG CHAIN & Gilles BRUYLANTS
14:00 — Dr Davide BRAMBILLA, University of Geneva, Switzerland
Phospholipid nanoparticles for lipase deficiency gene replacement therapy
14:30 — Makoni PEDZISAI, Sefako Makgatho Health Sciences University, South Africa
Overcoming levodopa hydrophilicity for nose-to-brain delivery: from cationic nanocrystals to a lipid-directed octyl ester strategy
14:45 — Viet-Ha PHAN, University of Bordeaux, France
Poly(oxazoline) coating on lipid nanoparticles as PEG alternative for pulmonary siRNA delivery
15:00 — Dr Sarah NIETO, Bordeaux INP, France
Biodegradable and dual-targeting polymersomes for site-specific drug delivery against Parkinson’s Disease
15:15 — Dr Marine LE GOAS, University of Paris Saclay, France
Differential dynamic microscopy as a versatile tool for in situ characterization of nanoparticles under realistic biological conditions
15:30 — Coffee break and Poster set up Session B
16:00 — Prof Sylvie BEGIN, Strasbourg, France
Engineering of surfactant coated iron oxide nanostructures to improve phosphate removal in peritoneal dialysis treatment
16:30 — Dr Guillaume BASTIAT, University of Angers, France
Derived Count Rate from dynamic light scattering as a quantitative tool for lipid nanoparticle concentration analysis: A double blind study
Early Talent Session
Chairpersons: Hiba HASSOUN & Milad BAROUD
16:45 — Early Talents Session and PhD award
Best PhD Award: Mélina GUÉRIN, University of Angers, France
Engineering self-assembled manomedicines for effective inhaled cancer therapy by overcoming the lung microbiota barrier
Yann DUCHESNE, Sanofi, France
Supramolecular assemblies of functionalized cyclodextrins for nucleic acid transfection
Syed NAFIS SHADMAN ALI, University of Grenoble Alps, France
Overcoming thermo-resistance in lung cancer: Gold nanoclusters for combined photothermal therapy and siRNA delivery
Zuzana KADLECOVA, HEPIA, University of Applied Sciences and Arts Western Switzerland, Switzerland
Liposomes & RM-LNCs in novel anti-RSV peptide encapsulation: from formulation to penetration through an artificial lung mucus model
Dr Abdelrahman REZK, University of Copenhagen, Denmark
Tuning the Gastrointestinal Protein Corona Through Systematically Controlled Nanoparticle Surface Modification
Nicolas POTIER, University of Lorraine, France
Physicochemical and Nano-/Microstructural Characterization of Osteoarthritic Synovial Fluid for Flow Behavior Assessment in Nano- and Microfluidic Systems
Hassan ABDERLAHMAN, University Paris Cité, France
From Nano-Crystallization to Crystal Structure of Fisetin through Multimodal Characterization
18:30 — Departure for Gala Diner
Wednesday
8:30 — Registration
SESSION 4 — New approaches for nanomedicine: Immunity, and vaccination
Chairpersons: Claire MONGE & Cédric CHAUVIERRE
9:00 — Pr Ana BELOQUI, Leuven, Belgium
Nanomedicine-based strategies in the treatment of metabolic gastrointestinal disorders
9:30 — Constanza MORENO-MARTINEZ, Institut de Recherche de Chimie Paris, France
Lipid Nanoparticle Mobility in Intestinal Mucus for Oral Delivery Applications
9:45 — Laila EMAM, University Versailles Saint Quentin, France
Lung delivery of Dexamethasone palmitate nanoparticles: an efficient treatment for severe inflammation
10:00 — Dr Emilie VELOT, University of Lorraine, France
Extracellular Vesicles (EVs) versus EVs: Mesenchymal stromal cell-derived EVs rescue bacterial EVs-induced Blood-Brain Barrier dysfunction
10:15 — Coffee break and Poster Session B
10:45 — Dr Ine LENTACKER, Ghent University, Belgium
Clinical translation of mRNA Galsomes – a glycolipid adjuvanted mRNA vaccine
11:15 — Dr Nabila LAROUI, University of Orléans, France
From systemic to mucosal vaccination: developing LNPs for nasal mRNA delivery
11:30 — Chloé MUZARD, University Paris Cité, France
Development of lipid nanoparticles for mRNA delivery in the treatment of type-2 asthma
11:45 — Alicia PRIEUR, University of Lyon, France
Design and optimization of nanoparticles for mucosal vaccine by intranasal administration
12:00 — Lunch and Poster Session B
SESSION 5 — New Market Trends
Chairpersons: Elise LEPELTIER & Yohann CORVIS
13:30 — Pr Florence GAZEAU, University of Paris Cité, France
Nanomedicine to democratize cancer immunotherapies
14:00 — Kelly AUBERTIN, University Paris Cité, France
Machine Learning-Enhanced Raman Spectroscopy: A Novel Approach for Extracellular Vesicle Classification
14:15 — Mahaut DE BERRANGER, University of Dijon, France
Synthesis of colloidally stable gold-silica nanoassemblies for theranostic applications
14:30 — Zeinab ALSAHLY, University of Lorraine, France
Efficacy and Safety Assessment of Iron Nanoclusters for treating Iron Deficiency
14:45 — Ines NIKOLIC, University of Geneva, Switzerland
Beyond Protein Corona: A Case Study with Clinically Approved Iron-Carbohydrate Nanomedicines
15:00 — Dr Rémi ROSIERE, InhaTarget Therapeutics, Belgium
Inhaled lipid nanoparticles targeting lung tumours and their microenvironment
15:30 — SFNano Awards and Final conclusion
Don’t miss this session!
16h00 — Meeting closure